← Eichor
Condition: Blood Donors Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Blood Donors

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Effect of Phlebotomy on Heartrate in Polycythemia Patients
Phase N/A · 1 location(s) · Leiden University Medical Center · NCT05396170A Phase 1/3 Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Ce
Phase 1 · 21 location(s) · TScan Therapeutics, Inc. · NCT05473910Methods of T Cell Depletion Trial (MoTD)
Phase 2 · 17 location(s) · University of Birmingham · NCT04888741Normal Donor Blood Draws for Platelet Studies and Biomarker Evaluation (ND-PLT)
Phase N/A · 1 location(s) · The Cleveland Clinic · NCT05628974Analysis of the Reliability and Validity of Laser Speckle Contrast Imaging
NA · 1 location(s) · Universidad Complutense de Madrid · NCT07527351Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
Phase 3 · 4 location(s) · Center for International Blood and Marrow Transplant Researc · NCT00785525Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
Phase 2 · 1 location(s) · Masonic Cancer Center, University of Minnesota · NCT03314974CHRONO-MOBILIZE: Chronotherapy of G-CSF for CD34+ Mobilization in Healthy Donors
NA · 3 location(s) · First Affiliated Hospital of Zhejiang University · NCT07423728Combined Light, ExVivo, and Antivirals for Recipients of Lungs From HBV Donors
Phase 4 · 1 location(s) · University Health Network, Toronto · NCT07189377Revisiting the Universal Donor: Does Exposure to O Blood Products Affect Patient Outcomes?
NA · 1 location(s) · McMaster University · NCT04859218Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use
Phase N/A · 1 location(s) · National Institutes of Health Clinical Center (CC) · NCT00001846A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patie
Phase 2 · 13 location(s) · Center for International Blood and Marrow Transplant Researc · NCT06859424Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-inten
Phase 2 · 10 location(s) · University of Liege · NCT03852407Improving White Blood Cell Collection From Healthy Donors
Phase 4 · 1 location(s) · National Institutes of Health Clinical Center (CC) · NCT01553214REVEAL Biomarkers of Engraftment After Alternative Donor HSCT
Phase 1 · 4 location(s) · University of Oklahoma · NCT03541889Trifecta-Kidney cfDNA-MMDx Study
Phase N/A · 31 location(s) · University of Alberta · NCT04239703A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transpl
Phase 3 · 26 location(s) · TScan Therapeutics, Inc. · NCT07702578A Study Testing an Improved Dose of UM171 to Help Make Cord Blood Transplants More Effective and Safe.
Phase 1/Phase 2 · 1 location(s) · Ciusss de L'Est de l'Île de Montréal · NCT07301866Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling
Phase 2 · 1 location(s) · University of Calgary · NCT03214354Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT01861106Repeat Peripheral Blood Stem Cell Transplantation for Patients With Sickle Cell Disease and Falling Donor Myeloid Chimer
Phase 1/Phase 2 · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT04008368Tulane Abdominal Transplant Institute (TATI) of Solid Organ Transplantation of HIV-Positive Recipients From HIV-Positive
Phase N/A · 1 location(s) · Tulane University · NCT05159466Low-Dose ATG/PTCy Plus Ivarmacitinib for aGVHD Prevention in Haplo-PBSCT From Parous Female Donors
Phase 2 · 1 location(s) · Shanghai General Hospital, Shanghai Jiao Tong University Sch · NCT07570745Study of Combined Kidney and Blood Stem Cell Transplant From a Brother or Sister Donor
Phase 1/Phase 2 · 1 location(s) · Jeffrey Veale, MD · NCT03707262Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT07410494Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)
NA · 18 location(s) · Johns Hopkins University · NCT06263426Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Ste
EARLY_Phase 1 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT06398457Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers
Phase 2 · 10 location(s) · Fred Hutchinson Cancer Center · NCT03779854Immune Reconstitution in Stem Cell Transplant Recipients
Phase N/A · 1 location(s) · University of Miami · NCT02129543grouP O wholE blooD : storagE leSion impacT And infLammation
NA · 1 location(s) · Etablissement Français du Sang · NCT06809010
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.